Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 20/20 | 0.49 |
| ▸ | CCND1 | P24385 | 13/20 | 0.49 |
| ▸ | CCND3 | P30281 | 12/20 | 0.49 |
| ▸ | CCND2 | P30279 | 11/20 | 0.49 |
| ▸ | CDK2 | P24941 | 4/20 | 0.49 |
| ▸ | CDK6 | Q00534 | 8/20 | 0.49 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.47 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.47 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.47 |
| ▸ | CDK9 | P50750 | 2/20 | 0.46 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.46 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.46 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.46 |
| ▸ | CCNT2 | O60583 | 1/20 | 0.46 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.46 |
| ▸ | STK16 | O75716 | 1/20 | 0.46 |
| ▸ | CCNK | O75909 | 1/20 | 0.46 |
| ▸ | PDE5A | O76074 | 1/20 | 0.46 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.46 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2076205 | 0.86 | CDK4 (0.66) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL16248285 | 0.86 | CDK4 (0.57) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL29600291 | 0.86 | CDK4 (0.66) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL16248264 | 0.85 | CDK4 (0.52) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL28488685 | 0.82 | CDK4 (0.67) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL4721497 | 0.80 | CDK4 (0.60) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL20448709 | 0.80 | CDK4 (0.60) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL2077623 | 0.80 | CDK4 (0.70) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL20448665 | 0.79 | CDK4 (0.57) | CDK4CCND1CCND3CCND2CDK2 | |
| SCHEMBL20490014 | 0.79 | CDK4 (0.66) | CDK4CCND1CCND3CCND2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10030018-B2 | Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2018-07-24 | — | — | US | disclosed |
| US-10030018-B2 | Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2018-07-24 | — | — | US | disclosed |
| US-20180009804-A1 | HYDROXYETHYL SULFONATE OF CYCLIN-DEPENDENT PROTEIN KINASE INHIBITOR, CRYSTALLINE FORM THEREOF AND PREPARATION METHOD THEREFOR | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2018-01-11 | — | — | US | disclosed |
| WO-2014183520-A1 | THIOPHENE MIAZINES DERIVATE, PREPARATION METHOD THEREFOR, AND MEDICAL APPLICATION THEREOF | 上海恒瑞医药有限公司 (CN) | 2014-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10030018-B2 | Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor | WEE1, WEE2, CDK2 | CDK4 6/4885CCND1 45/4885CCND3 61/4885 |
| US-20180009804-A1 | HYDROXYETHYL SULFONATE OF CYCLIN-DEPENDENT PROTEIN KINASE INHIBITOR, CRYSTALLINE FORM THEREOF AND PREPARATION METHOD THEREFOR | WEE1, WEE2, CDK2 | CDK4 6/4885CCND1 45/4885CCND3 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.